NXG Nexgenrx Inc

NEXGENRX INC. ("NexgenRx" or the "Corporation") (TSX VENTURE:NXG) is pleased to
announce the appointment of Mr. Barry J. Reiter as a director of the
Corporation.


Barry Reiter is a partner with the law firm Bennett Jones LLP. Mr. Reiter is
Chair of the Technology, Media and Entertainment Group for his firm. He is also
the Bennett Jones leader of the Director Protection and Corporate Governance
practice. Mr. Reiter is an experienced director and has chaired boards and
various board committees for public and private companies. Current board roles
include: Syncapse Corp., HUB International (Advisory Board), and the Executive
Committee of the Institute of Corporate Directors (Ontario Chapter). Mr. Reiter
speaks regularly at director education and certification programs. Formerly a
law professor at the Faculty of Law, University of Toronto (1974-1982), Mr.
Reiter has published books and articles on governance matters and is lead author
of Directors' Duties in Canada, 4th Edition, published by CCH Canadian Limited
in 2009.


"We are thrilled to welcome Barry to our Board" stated Thomas F. Corcoran,
Chairman and a director of NexgenRx. "With his proven knowledge and expertise in
corporate governance, we are fortunate to add him as a member of our board and
look forward to working with him to further strengthen our market position and
corporate governance practices."


About NexgenRx

NexgenRx is a growing health benefits management company engaged in the design,
management and administration of health benefit plans offered by employers and
other plan sponsors for the benefit of their employees and plan members. More
information on NexgenRx can be found at www.nexgenrx.com. 


Caution Regarding Forward-Looking Statements - This news release contains
certain forward looking statements, including statements regarding the business
and anticipated financial performance of the Corporation. These statements are
subject to a number of risks and uncertainties. Actual results may differ
materially from results contemplated by the forward-looking statements. When
relying on forward-looking statements to make decisions, investors and others
should carefully consider the foregoi ng factors and other uncertainties and
should not place undue reliance on such forward-looking statements. 


FOR FURTHER INFORMATION PLEASE CONTACT: 
NexgenRx Inc.
Ronald C. Loucks
President and CEO
416.695.3393 x801


NexgenRx Inc.
Taba Merrikh
Director of Finance
416-695-3393x803
www.nexgenrx.com

Nexgenrx (TSXV:NXG)
Historical Stock Chart
From May 2024 to Jun 2024

Nexgenrx (TSXV:NXG)
Historical Stock Chart
From Jun 2023 to Jun 2024